vs
Dynatrace, Inc.（DT）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是Dynatrace, Inc.的1.2倍（$622.0M vs $515.5M），Royalty Pharma plc净利率更高（34.4% vs 7.8%，领先26.7%），Dynatrace, Inc.同比增速更快（18.2% vs 4.8%），过去两年Dynatrace, Inc.的营收复合增速更高（16.3% vs 4.6%）
Dynatrace是总部位于美国的跨国科技企业，主打AI驱动的可观测性平台，旗下软件可用于应用性能监控分析、软件开发流程优化、网络安全防护、IT基础设施运维及用户体验提升等场景，为各行业客户的数字化运营提供有力技术支撑。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
DT vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.2倍
$515.5M
营收增速更快
DT
高出13.4%
4.8%
净利率更高
RPRX
高出26.7%
7.8%
两年增速更快
DT
近两年复合增速
4.6%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $515.5M | $622.0M |
| 净利润 | $40.1M | $214.2M |
| 毛利率 | 81.4% | — |
| 营业利润率 | 14.1% | 62.4% |
| 净利率 | 7.8% | 34.4% |
| 营收同比 | 18.2% | 4.8% |
| 净利润同比 | -88.9% | 2.9% |
| 每股收益（稀释后） | $0.13 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DTRPRX
| Q4 25 | $515.5M | $622.0M | ||
| Q3 25 | $493.8M | $609.3M | ||
| Q2 25 | $477.3M | $578.7M | ||
| Q1 25 | $445.2M | $568.2M | ||
| Q4 24 | $436.2M | $593.6M | ||
| Q3 24 | $418.1M | $564.7M | ||
| Q2 24 | $399.2M | $537.3M | ||
| Q1 24 | $380.8M | $568.0M |
净利润DTRPRX
| Q4 25 | $40.1M | $214.2M | ||
| Q3 25 | $57.2M | $288.2M | ||
| Q2 25 | $48.0M | $30.2M | ||
| Q1 25 | $39.3M | $238.3M | ||
| Q4 24 | $361.8M | $208.2M | ||
| Q3 24 | $44.0M | $544.0M | ||
| Q2 24 | $38.6M | $102.0M | ||
| Q1 24 | $37.9M | $4.8M |
毛利率DTRPRX
| Q4 25 | 81.4% | — | ||
| Q3 25 | 81.8% | — | ||
| Q2 25 | 82.1% | — | ||
| Q1 25 | 80.9% | — | ||
| Q4 24 | 81.1% | — | ||
| Q3 24 | 81.4% | — | ||
| Q2 24 | 81.3% | — | ||
| Q1 24 | 81.1% | — |
营业利润率DTRPRX
| Q4 25 | 14.1% | 62.4% | ||
| Q3 25 | 14.8% | 70.1% | ||
| Q2 25 | 13.1% | 36.3% | ||
| Q1 25 | 9.6% | 94.0% | ||
| Q4 24 | 10.9% | 60.9% | ||
| Q3 24 | 11.2% | — | ||
| Q2 24 | 10.5% | 50.2% | ||
| Q1 24 | 6.1% | -13.0% |
净利率DTRPRX
| Q4 25 | 7.8% | 34.4% | ||
| Q3 25 | 11.6% | 47.3% | ||
| Q2 25 | 10.0% | 5.2% | ||
| Q1 25 | 8.8% | 41.9% | ||
| Q4 24 | 82.9% | 35.1% | ||
| Q3 24 | 10.5% | 96.3% | ||
| Q2 24 | 9.7% | 19.0% | ||
| Q1 24 | 10.0% | 0.8% |
每股收益（稀释后）DTRPRX
| Q4 25 | $0.13 | $0.49 | ||
| Q3 25 | $0.19 | $0.67 | ||
| Q2 25 | $0.16 | $0.07 | ||
| Q1 25 | $0.12 | $0.55 | ||
| Q4 24 | $1.19 | $0.46 | ||
| Q3 24 | $0.15 | $1.21 | ||
| Q2 24 | $0.13 | $0.23 | ||
| Q1 24 | $0.13 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.2B | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $2.7B | $9.7B |
| 总资产 | $4.1B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资DTRPRX
| Q4 25 | $1.2B | $618.7M | ||
| Q3 25 | $1.3B | $938.9M | ||
| Q2 25 | $1.3B | $631.9M | ||
| Q1 25 | $1.1B | $1.1B | ||
| Q4 24 | $1.0B | $929.0M | ||
| Q3 24 | $1.0B | $950.1M | ||
| Q2 24 | $1.0B | $1.8B | ||
| Q1 24 | $836.9M | $843.0M |
总债务DTRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益DTRPRX
| Q4 25 | $2.7B | $9.7B | ||
| Q3 25 | $2.8B | $9.6B | ||
| Q2 25 | $2.7B | $9.5B | ||
| Q1 25 | $2.6B | $9.8B | ||
| Q4 24 | $2.6B | $10.3B | ||
| Q3 24 | $2.1B | $10.3B | ||
| Q2 24 | $2.1B | $9.8B | ||
| Q1 24 | $2.0B | $9.9B |
总资产DTRPRX
| Q4 25 | $4.1B | $19.6B | ||
| Q3 25 | $4.1B | $19.3B | ||
| Q2 25 | $4.1B | $18.3B | ||
| Q1 25 | $4.1B | $17.6B | ||
| Q4 24 | $3.7B | $18.2B | ||
| Q3 24 | $3.3B | $18.0B | ||
| Q2 24 | $3.3B | $17.7B | ||
| Q1 24 | $3.4B | $16.1B |
负债/权益比DTRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $33.8M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $27.2M | — |
| 自由现金流率自由现金流/营收 | 5.3% | — |
| 资本支出强度资本支出/营收 | 1.3% | — |
| 现金转化率经营现金流/净利润 | 0.84× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $465.5M | — |
8季度趋势，按日历期对齐
经营现金流DTRPRX
| Q4 25 | $33.8M | $827.1M | ||
| Q3 25 | $32.0M | $702.6M | ||
| Q2 25 | $269.7M | $364.0M | ||
| Q1 25 | $162.8M | $596.1M | ||
| Q4 24 | $42.2M | $742.5M | ||
| Q3 24 | $23.6M | $703.6M | ||
| Q2 24 | $230.7M | $658.2M | ||
| Q1 24 | $131.7M | $664.6M |
自由现金流DTRPRX
| Q4 25 | $27.2M | — | ||
| Q3 25 | $27.8M | — | ||
| Q2 25 | $262.2M | — | ||
| Q1 25 | $148.2M | — | ||
| Q4 24 | $37.6M | — | ||
| Q3 24 | $20.1M | — | ||
| Q2 24 | $227.4M | — | ||
| Q1 24 | $121.9M | — |
自由现金流率DTRPRX
| Q4 25 | 5.3% | — | ||
| Q3 25 | 5.6% | — | ||
| Q2 25 | 54.9% | — | ||
| Q1 25 | 33.3% | — | ||
| Q4 24 | 8.6% | — | ||
| Q3 24 | 4.8% | — | ||
| Q2 24 | 57.0% | — | ||
| Q1 24 | 32.0% | — |
资本支出强度DTRPRX
| Q4 25 | 1.3% | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 1.6% | — | ||
| Q1 25 | 3.3% | — | ||
| Q4 24 | 1.1% | — | ||
| Q3 24 | 0.8% | — | ||
| Q2 24 | 0.8% | — | ||
| Q1 24 | 2.6% | — |
现金转化率DTRPRX
| Q4 25 | 0.84× | 3.86× | ||
| Q3 25 | 0.56× | 2.44× | ||
| Q2 25 | 5.62× | 12.06× | ||
| Q1 25 | 4.14× | 2.50× | ||
| Q4 24 | 0.12× | 3.57× | ||
| Q3 24 | 0.54× | 1.29× | ||
| Q2 24 | 5.97× | 6.45× | ||
| Q1 24 | 3.47× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DT
| Subscription And Circulation | $493.4M | 96% |
| Services | $22.1M | 4% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
